Goodman Advisory Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $178K | Sell |
400
-44
| -10% | -$19.6K | 0.06% | 59 |
|
|
2025
Q1 | $215K | Buy |
+444
| New | +$215K | 0.07% | 75 |
|
|
2024
Q4 | – | Sell |
-492
| Closed | -$229K | – | 180 |
|
|
2024
Q3 | $229K | Hold |
492
| – | – | 0.07% | 80 |
|
|
2024
Q2 | $231K | Sell |
492
-7
| -1% | -$3.28K | 0.07% | 79 |
|
|
2024
Q1 | $209K | Buy |
499
+7
| +1% | +$2.93K | 0.07% | 69 |
|
|
2023
Q4 | $200K | Hold |
492
| – | – | 0.07% | 67 |
|
|
2023
Q3 | $171K | Sell |
492
-29
| -6% | -$10.1K | 0.06% | 70 |
|
|
2023
Q2 | $183K | Hold |
521
| – | – | 0.07% | 59 |
|
|
2023
Q1 | $164K | Sell |
521
-274
| -34% | -$86.3K | 0.09% | 52 |
|
|
2022
Q4 | $230K | Buy |
795
+274
| +53% | +$79.3K | 0.13% | 43 |
|
|
2022
Q3 | $151K | Hold |
521
| – | – | 0.08% | 53 |
|
|
2022
Q2 | $147K | Buy |
+521
| New | +$147K | 0.07% | 55 |
|